Northern Trust
SGMO

Northern Trust’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Northern Trust’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Hold
737,867
– – ﹤0.01% 3973
2025
Q4 		$310K Buy
737,867
+98,187
+15% +$52K ﹤0.01% 3820
2025
Q3 		$431K Buy
639,680
+243,527
+61% +$131K ﹤0.01% 3701
2025
Q2 		$214K Sell
396,153
-2,157
-0.5% -$1.28K ﹤0.01% 3914
2025
Q1 		$261K Buy
398,310
+21
+0% +$22 ﹤0.01% 3844
2024
Q4 		$406K Buy
398,289
+17,049
+4% +$31.2K ﹤0.01% 3727
2024
Q3 		$330K Sell
381,240
-819,807
-68% -$601K ﹤0.01% 3704
2024
Q2 		$430K Sell
1,201,047
-27,838
-2% -$15K ﹤0.01% 3559
2024
Q1 		$824K Sell
1,228,885
-37,931
-3% -$27.5K ﹤0.01% 3397
2023
Q4 		$688K Buy
1,266,816
+76,869
+6% +$35.4K ﹤0.01% 3438
2023
Q3 		$714K Sell
1,189,947
-12,022
-1% -$12.9K ﹤0.01% 3403
2023
Q2 		$1.56M Sell
1,201,969
-46,045
-4% -$62.9K ﹤0.01% 3156
2023
Q1 		$2.2M Sell
1,248,014
-39,149
-3% -$112K ﹤0.01% 2899
2022
Q4 		$4.04M Buy
1,287,163
+72,962
+6% +$283K ﹤0.01% 2610
2022
Q3 		$5.95M Buy
1,214,201
+48,370
+4% +$248K ﹤0.01% 2359
2022
Q2 		$4.83M Sell
1,165,831
-33,407
-3% -$144K ﹤0.01% 2538
2022
Q1 		$6.97M Sell
1,199,238
-37,828
-3% -$225K ﹤0.01% 2370
2021
Q4 		$9.28M Sell
1,237,066
-217,931
-15% -$1.89M ﹤0.01% 2283
2021
Q3 		$13.1M Sell
1,454,997
-36,445
-2% -$360K ﹤0.01% 2090
2021
Q2 		$17.9M Buy
1,491,442
+143,240
+11% +$1.62M ﹤0.01% 1966
2021
Q1 		$16.9M Sell
1,348,202
-92,118
-6% -$1.24M ﹤0.01% 1952
2020
Q4 		$22.5M Sell
1,440,320
-49,628
-3% -$581K ﹤0.01% 1706
2020
Q3 		$14.1M Sell
1,489,948
-84,559
-5% -$915K ﹤0.01% 1883
2020
Q2 		$14.1M Buy
1,574,507
+121,465
+8% +$1.13M ﹤0.01% 1883
2020
Q1 		$9.26M Sell
1,453,042
-51,565
-3% -$383K ﹤0.01% 1904
2019
Q4 		$12.6M Sell
1,504,607
-10,125
-0.7% -$93.1K ﹤0.01% 2031
2019
Q3 		$13.7M Buy
1,514,732
+141,263
+10% +$1.58M ﹤0.01% 1949
2019
Q2 		$14.8M Buy
1,373,469
+51,137
+4% +$544K ﹤0.01% 1894
2019
Q1 		$12.6M Buy
1,322,332
+821
+0.1% +$8.38K ﹤0.01% 1998
2018
Q4 		$15.2M Sell
1,321,511
-1,455
-0.1% -$18.1K ﹤0.01% 1796
2018
Q3 		$22.4M Buy
1,322,966
+35,166
+3% +$534K 0.01% 1705
2018
Q2 		$18.3M Buy
1,287,800
+223,870
+21% +$3.72M ﹤0.01% 1851
2018
Q1 		$20.2M Buy
1,063,930
+2,998
+0.3% +$64.1K 0.01% 1677
2017
Q4 		$17.4M Sell
1,060,932
-8,163
-0.8% -$121K ﹤0.01% 1821
2017
Q3 		$16M Buy
1,069,095
+121,263
+13% +$1.34M ﹤0.01% 1874
2017
Q2 		$8.34M Buy
947,832
+44,656
+5% +$286K ﹤0.01% 2290
2017
Q1 		$4.7M Buy
903,176
+10,400
+1% +$41.7K ﹤0.01% 2589
2016
Q4 		$2.72M Buy
892,776
+7,906
+0.9% +$28.8K ﹤0.01% 2918
2016
Q3 		$4.1M Buy
884,870
+5,414
+0.6% +$27.5K ﹤0.01% 2644
2016
Q2 		$5.09M Buy
879,456
+34,772
+4% +$222K ﹤0.01% 2452
2016
Q1 		$5.11M Buy
844,684
+18,948
+2% +$114K ﹤0.01% 2398
2015
Q4 		$7.54M Buy
825,736
+17,424
+2% +$134K ﹤0.01% 2201
2015
Q3 		$4.56M Buy
808,312
+22,379
+3% +$185K ﹤0.01% 2493
2015
Q2 		$8.72M Sell
785,933
-7,557
-1% -$97.4K ﹤0.01% 2154
2015
Q1 		$12.4M Buy
793,490
+14,633
+2% +$226K ﹤0.01% 1934
2014
Q4 		$11.8M Sell
778,857
-31,667
-4% -$385K ﹤0.01% 1942
2014
Q3 		$8.74M Sell
810,524
-40,970
-5% -$535K ﹤0.01% 2130
2014
Q2 		$13M Sell
851,494
-9,852
-1% -$142K ﹤0.01% 1846
2014
Q1 		$15.6M Sell
861,346
-58,931
-6% -$1.14M ﹤0.01% 1780
2013
Q4 		$12.8M Buy
920,277
+89,601
+11% +$1.03M ﹤0.01% 1905
2013
Q3 		$8.71M Buy
830,676
+10,919
+1% +$108K ﹤0.01% 2114
2013
Q2 		$6.4M Buy
+819,757
New +$7.15M ﹤0.01% 2249

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust's SGMO Position: Q1 2026 in Review

Northern Trust held its SANGAMO THERAPEUTICS INC (SGMO) position steady in Q1 2026 at 737,867 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3973.

Northern Trust first reported a position in SGMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $22.5M in Q4 2020. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • Northern Trust held 737,867 shares of SANGAMO THERAPEUTICS INC worth $182K as of Q1 2026.
  • Northern Trust left its SANGAMO THERAPEUTICS INC share count unchanged in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3973 holding.
  • Northern Trust first reported a position in SANGAMO THERAPEUTICS INC in Q2 2013 and has held it in 52 quarters since.
  • Northern Trust's SANGAMO THERAPEUTICS INC position peaked at $22.5M in Q4 2020.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.